Activated Hepatic Stellate Cell-derived Small Extracellular Vesicles Facilitate M2 Macrophage Polarization and Hepatoma Progression Via MiR-27a-3p

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2025 Jan 1

PMID 39742261

Authors

Yufeng Sun

Xiaoqian He

Jiayi Han

Wenxuan Yin

Haichen Wang

Jing Li

Weiqi Liu

Xingwang Kuai

Jiaying Lv

Juling Ji

Affiliations

Soon will be listed here.

Abstract

The progression of hepatoma is heavily influenced by the microenvironment. Tumor-associated macrophages (TAMs) are considered to play a critical role in the tumor microenvironment (TME) and increase the aggressiveness of hepatoma. The activation of hepatic stellate cells (HSCs) is involved in hepatoma progression, and accumulating evidence demonstrates a change in microRNA (miRNA) expression during HSC activation. Therefore, the potential roles of HSCs-related miRNAs in macrophage differentiation and hepatoma progression deserve to be explored. The present study aimed to investigate the effects of miRNAs carried by small extracellular vesicles (sEVs) released by activated HSCs on hepatoma progression. The results indicated that miR-27a-3p was significantly upregulated in cells and corresponding sEVs during the activation of primary rat HSCs and human HSC line-LX2 cells. Furthermore, miR-27a-3p contributed to the proliferation and migration of hepatoma cells and promoted M2 polarization of macrophage. HSC-sEVs overexpressing miR-27a-3p can directly facilitate tumor progression and modulate macrophage polarization, indirectly contributing to hepatoma progression. Finally, Sprouty2 (SPRY2) was verified to be the target gene of miR-27a-3p. In conclusion, activated HSC-derived sEVs with high levels of miR-27a-3p might induce M2 macrophage polarization and promote hepatoma progression, providing new insights into the mechanism of hepatoma progression.

References

Bachurski D, Schuldner M, Nguyen P, Malz A, Reiners K, Grenzi P . Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J Extracell Vesicles. 2019; 8(1):1596016. PMC: 6450530. DOI: 10.1080/20013078.2019.1596016. View

Atomura R, Sanui T, Fukuda T, Tanaka U, Toyoda K, Taketomi T . Inhibition of Sprouty2 polarizes macrophages toward an M2 phenotype by stimulation with interferon γ and Porphyromonas gingivalis lipopolysaccharide. Immun Inflamm Dis. 2016; 4(1):98-110. PMC: 4768065. DOI: 10.1002/iid3.99. View

Man K, Lo C, Liu X . M2 macrophages on tumour growth and metastasis in hepatocellular carcinoma. Hong Kong Med J. 2020; 25 Suppl 9(6):35-39. View

Wang C, Delogu S, Ho C, Lee S, Gui B, Jiang L . Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways. J Hepatol. 2012; 57(3):577-83. PMC: 3423481. DOI: 10.1016/j.jhep.2012.04.026. View

Zhang X, Chen F, Huang P, Wang X, Zhou K, Zhou C . Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma. Int J Biol Sci. 2022; 18(6):2249-2260. PMC: 8990464. DOI: 10.7150/ijbs.66184. View

Kanlikilicer P, Bayraktar R, Denizli M, Rashed M, Ivan C, Aslan B . Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018; 38:100-112. PMC: 6306310. DOI: 10.1016/j.ebiom.2018.11.004. View

Ji J, Eggert T, Budhu A, Forgues M, Takai A, Dang H . Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma. Hepatology. 2015; 62(2):481-95. PMC: 4515211. DOI: 10.1002/hep.27822. View

Sun Y, Li W, Shen S, Yang X, Lu B, Zhang X . Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis. J Transl Med. 2019; 17(1):390. PMC: 6880547. DOI: 10.1186/s12967-019-02138-5. View

Higashi T, Friedman S, Hoshida Y . Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017; 121:27-42. PMC: 5682243. DOI: 10.1016/j.addr.2017.05.007. View

10.

Chen Q, Gao B, Tong D, Huang C . Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment. Cancer Lett. 2022; 552:215979. DOI: 10.1016/j.canlet.2022.215979. View

11.

Thery C, Witwer K, Aikawa E, Alcaraz M, Anderson J, Andriantsitohaina R . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2019; 7(1):1535750. PMC: 6322352. DOI: 10.1080/20013078.2018.1535750. View

12.

Zongqiang H, Jiapeng C, Yingpeng Z, Chuntao Y, Yiting W, Jiashun Z . Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3. J Immunol Res. 2022; 2022:1032106. PMC: 9508462. DOI: 10.1155/2022/1032106. View

13.

Ji J, Yu F, Ji Q, Li Z, Wang K, Zhang J . Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response. Hepatology. 2012; 56(1):332-49. DOI: 10.1002/hep.25650. View

14.

Makino Y, Hikita H, Kodama T, Shigekawa M, Yamada R, Sakamori R . CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression. Cancer Res. 2018; 78(17):4902-4914. DOI: 10.1158/0008-5472.CAN-17-3844. View

15.

Thompson K, Trowern A, Fowell A, Marathe M, Haycock C, Arthur M . Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation In vitro. Hepatology. 1998; 28(6):1518-24. DOI: 10.1002/hep.510280611. View

16.

Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z . Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023; 8(1):124. PMC: 10017761. DOI: 10.1038/s41392-023-01382-y. View

17.

Ben W, Zhang G, Huang Y, Sun Y . MiR-27a-3p Regulated the Aggressive Phenotypes of Cervical Cancer by Targeting FBXW7. Cancer Manag Res. 2020; 12:2925-2935. PMC: 7198449. DOI: 10.2147/CMAR.S234897. View

18.

Dong G, Chen Z, Li Z, Yeh N, Bancroft C, Van Waes C . Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 2001; 61(15):5911-8. View

19.

Zhao F, Cheng L, Shao Q, Chen Z, Lv X, Li J . Characterization of serum small extracellular vesicles and their small RNA contents across humans, rats, and mice. Sci Rep. 2020; 10(1):4197. PMC: 7060188. DOI: 10.1038/s41598-020-61098-9. View

20.

Scheau C, Badarau I, Costache R, Caruntu C, Mihai G, Didilescu A . The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. Anal Cell Pathol (Amst). 2019; 2019:9423907. PMC: 6899323. DOI: 10.1155/2019/9423907. View